Top 4 Canadian Biotech Stocks (Updated October 2025)
Source: Investing News Network
2025-12-30 17:01:50 ET
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.
Here the Investing News Network profiles the five best-performing Canadian biotech stocks on the TSX, TSXV and CSE, based on year-on-year gains. Data on these companies was collected on October 20, 2025, using TradingView's stock screener , and companies with market caps above C$10 million at that time were considered.
Read on to learn what's been driving these Canadian biotech firms.
For further details see:
Top 4 Canadian Biotech Stocks (Updated October 2025)
Eupraxia Pharmaceuticals Inc.
NASDAQ: EPRX:CC
EPRX:CC Trading
0.0% G/L:
$1.05 Last:
6 Volume:
$0 Open:
EPRX:CC Latest News
February 20, 2026 03:10:55 pm
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 19, 2026 02:18:17 am
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants
January 08, 2026 03:30:38 pm
Canadian Companies Moving the Markets, Evening edition Thu, Jan 08, 2026 as of 4:00 pm ET
